Background/aim: The purpose of this study was to investigate proliferation and differentiation markers in colorectal adenocarcinoma and their correlation with clinicopathological factors. Materials and methods: Samples were collected from 38 patients with colorectal adenocarcinoma and 10 healthy controls. E-cadherin, carcinoembryonic antigen (mCEA), cyclin B1, vascular endothelial growth factor (VEGF), and erythropoietin (EPO) receptor (EPOR) were examined by immunohistochemistry; VEGF and EPO were examined by real-time PCR. Results: The tumor samples were mostly characterized by large dimension (pT3), moderate level of differentiation (G2), negative lymph node status (N0), and no metastasis. Cyclin B1 and VEGF gene and protein expressions were significantly higher in tumor tissues than in control tissues; E-cadherin expression was significantly decreased in tumor samples and in positive correlation with mCEA. EPO was almost undetectable in tumor tissues of colorectal adenocarcinoma. Significant positive correlation was detected between tumor size and cyclin B1, tumor grade, and lymph node status. Conclusion: Decreased expression of EPO, high levels of VEGF and cyclin B1 expression, predominant moderate tumor differentiation, absence of metastasis, and negative lymph node status may suggest low level of aggressiveness, better prognosis, and longer patient survival.
Adenocarcinoma of colon, E-cadherin, mCEA, cyclin B1, erythropoietin receptor, vascular endothelial growth factor, erythropoietin
AJTIC, OLIVERA MITROVIC; TODOROVIC, SLOBODAN; DIKLIC, MILOS; SUBOTICKI, TIJANA; BELESLIN-COKIC, BOJANA; JOVCIC, GORDANA; and COKIC, VLADAN
"Proliferation and differentiation markers of colorectal adenocarcinomaand their correlation with clinicopathological factors,"
Turkish Journal of Medical Sciences: Vol. 46:
4, Article 34.
Available at: https://journals.tubitak.gov.tr/medical/vol46/iss4/34